Keyphrases
Active Substances
20%
Active Treatment
40%
Analgesia
20%
Back Pain
20%
Biosignatures
100%
Brain Connectivity
20%
Chronic Low Back Pain (cLBP)
80%
Chronic Pain
100%
Chronic Pain Patients
20%
Dorsolateral Prefrontal Cortex (DLPFC)
20%
Drug Effects
20%
Functional Connectivity
20%
Group Level
40%
Intent-to-treat Analysis
20%
Low Back Pain Patients
60%
Naproxen
40%
Non-responders
80%
One-component
20%
Osteoarthritis Pain
20%
Pain Intensity
20%
Pain Patients
20%
Pain Relief
20%
Per-protocol Analysis
20%
Placebo
100%
Placebo Nonresponder
20%
Placebo Responder
20%
Placebo Response
40%
Placebo Study
20%
Placebo Treatment
40%
Precentral Gyrus
20%
Predictive Models
40%
Randomized Controlled Trial
100%
Separation Effect
20%
Single Subject
20%
Subject-level
20%
Treatment Response
40%
Trial Participants
20%
Twice a Day
20%
Medicine and Dentistry
Analgesia
14%
Analgesia Monitors
14%
Chronic Pain
100%
Dorsolateral Prefrontal Cortex
14%
Drug Effect
14%
Effect Size
14%
Functional Connectivity
28%
Intention-to-Treat Analysis
14%
Low Back Pain
57%
Naproxen
28%
Osteoarthritis
14%
Placebo
100%
Placebo Effect
28%
Placebo Studies
14%
Randomized Controlled Trial
100%
Treatment Response
28%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Pain
100%
Low Back Pain
40%
Naproxen
20%
Osteoarthritis
10%
Placebo
100%
Randomized Controlled Trial
100%
Psychology
Chronic Pain
100%
Dorsolateral Prefrontal Cortex
50%
Functional Connectivity
100%
Osteoarthritis
50%
Immunology and Microbiology
Back
100%
Dorsolateral Prefrontal Cortex
25%
Drug Effect
25%
Functional Connectivity
50%
Osteoarthritis
25%
Placebo Effect
50%
Neuroscience
Dorsolateral Prefrontal Cortex
10%
Functional Connectivity
20%
Gyri
10%
Naproxen
20%
Placebo
100%
Randomized Controlled Trial
100%